ESR1 and breast cancer: Reuben et al. investigated the ERα status of circulating tumour cells in metastatic breast cancer patients and their corresponding primary tumours: fourteen of 16 patients (88%) had ERα-positive primary tumours, but only three patients had ERα-positive circulating tumour cells [17].